A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
- 1 July 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 281 (1) , 81-88
- https://doi.org/10.1016/0014-2999(95)00234-c
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranesPublished by Elsevier ,2003
- Characterisation of the Binding of [3H]WAY‐100635, a Novel 5‐Hydroxytryptamine1A Receptor Antagonist, to Rat BrainJournal of Neurochemistry, 1995
- [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomographyLife Sciences, 1994
- Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216—525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleusNeuropharmacology, 1994
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsNeuron, 1993
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- (S)-N-tert-Butyl-3-(4-(2-methoxyphenyl)piperazin-1-yl)-2-phenylpropanamide [(S)-WAY-100135]: a selective antagonist at presynaptic and postsynaptic 5-HT1A receptorsJournal of Medicinal Chemistry, 1993
- Treatment strategies for Alzheimer's diseaseThe Lancet, 1992
- (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonistJournal of Medicinal Chemistry, 1990